[The effects of coronary actve drugs on membrane metabolism and permeability].
D000217:Acyltransferases / Q000037:antagonists & inhibitors; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001667:Binding, Competitive; D001679:Biogenic Amines / Q000378:metabolism; D001692:Biological Transport / Q000187:drug effects; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism; D002462:Cell Membrane / Q000187:drug effects* / Q000378:metabolism; D002463:Cell Membrane Permeability / Q000187:drug effects*; D004837:Epinephrine / Q000378:metabolism; D004912:Erythrocytes / Q000187:drug effects / Q000201:enzymology; D006801:Humans; D010710:Phosphates / Q000378:metabolism; D010740:Phospholipases / Q000037:antagonists & inhibitors; D010743:Phospholipids / Q000378:metabolism; D011427:Propiophenones / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology; D014439:Tyramine / Q000378:metabolism; D014665:Vasodilator Agents / Q000494:pharmacology*
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D000889:Anti-Arrhythmia Agents; D001679:Biogenic Amines; D010710:Phosphates; D010743:Phospholipids; D011427:Propiophenones; D011437:Propylamines; D013566:Sympathomimetics; D014665:Vasodilator Agents; D000217:Acyltransferases; D010740:Phospholipases; D014439:Tyramine; D004837:Epinephrine
Der Einfluss herzwirk samer Pharmaka auf Membranstoffwechsel und -permeabilität.